Pacira BioSciences, Inc. PCRX Business Segments — Total net product sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s business segments — total net product sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s business segments — total net product sales?
- Pacira BioSciences, Inc. (PCRX) reported business segments — total net product sales of $177.38M in Q1 2026.
- How has Pacira BioSciences, Inc.'s business segments — total net product sales changed year-over-year?
- Pacira BioSciences, Inc.'s business segments — total net product sales increased by 5.0% year-over-year, from $168.92M to $177.38M.
- What is the long-term trend for Pacira BioSciences, Inc.'s business segments — total net product sales?
- Over 3 years (2022 to 2025), Pacira BioSciences, Inc.'s business segments — total net product sales has grown at a 2.9% compound annual growth rate (CAGR), from $666.82M to $726.41M.
- What does business segments — total net product sales mean?
- Represents the total revenue generated from the sale of products within a specific reportable business segment after accounting for returns, allowances, and discounts. This metric serves as the primary indicator of market demand and commercial performance for the segment's product portfolio.